ARWR - Arrowhead Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.51B
Enterprise Value 32.23B
Trailing P/E 259.31
Forward P/E 1-97.96
PEG Ratio (5 yr expected) 14.90
Price/Sales (ttm)26.46
Price/Book (mrq)12.45
Enterprise Value/Revenue 323.52
Enterprise Value/EBITDA 6209.80

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 10.09%
Operating Margin (ttm)6.19%

Management Effectiveness

Return on Assets (ttm)1.59%
Return on Equity (ttm)6.09%

Income Statement

Revenue (ttm)94.79M
Revenue Per Share (ttm)1.05
Quarterly Revenue Growth (yoy)7,306.00%
Gross Profit (ttm)16.14M
EBITDA 10.63M
Net Income Avi to Common (ttm)9.57M
Diluted EPS (ttm)0.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)218.2M
Total Cash Per Share (mrq)2.3
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.31
Book Value Per Share (mrq)2.12

Cash Flow Statement

Operating Cash Flow (ttm)131.61M
Levered Free Cash Flow (ttm)94.05M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.88
52-Week Change 384.17%
S&P500 52-Week Change 34.50%
52 Week High 327.69
52 Week Low 310.41
50-Day Moving Average 322.09
200-Day Moving Average 317.80

Share Statistics

Avg Vol (3 month) 32M
Avg Vol (10 day) 31.66M
Shares Outstanding 594.81M
Float 86.36M
% Held by Insiders 18.81%
% Held by Institutions 163.80%
Shares Short (May 31, 2019) 419.15M
Short Ratio (May 31, 2019) 46.11
Short % of Float (May 31, 2019) 420.92%
Short % of Shares Outstanding (May 31, 2019) 420.19%
Shares Short (prior month Apr 30, 2019) 413.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Nov 17, 2011